
    
      The CONFIDENCE registry study will be conducting as a prospective, non-randomized,
      observational, single-arm, multi-center study.

      Approximately 1000 subjects with severe symptomatic (NYHA class ≥ II) aortic stenosis (AS),
      will undergo Portico™ Transcatheter Aortic Heart Valve implantation.

      The subject data will be collected at baseline, index procedure, pre- discharge, 30 days and
      12 months from the index procedure.
    
  